XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 106 filers reported holding XERIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $23,000 | -83.3% | 5,109 | -81.7% | 0.00% | – |
| Q4 2020 | $138,000 | +331.2% | 27,908 | +416.1% | 0.00% | – |
| Q3 2020 | $32,000 | +88.2% | 5,408 | -16.3% | 0.00% | – |
| Q2 2020 | $17,000 | +30.8% | 6,458 | +5.3% | 0.00% | – |
| Q1 2020 | $13,000 | -65.8% | 6,134 | +13.1% | 0.00% | – |
| Q4 2019 | $38,000 | -13.6% | 5,425 | +21.6% | 0.00% | – |
| Q3 2019 | $44,000 | -8.3% | 4,461 | 0.0% | 0.00% | – |
| Q2 2019 | $48,000 | +37.1% | 4,461 | +27.9% | 0.00% | – |
| Q1 2019 | $35,000 | +105.9% | 3,487 | +247.0% | 0.00% | – |
| Q4 2018 | $17,000 | -5.6% | 1,005 | 0.0% | 0.00% | – |
| Q3 2018 | $18,000 | – | 1,005 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|